NAT10 and colorectal cancer: Using NAT10 as a target to develop clinical drugs has strong potential clinical value However, the limitation of this study is that further studies are still needed to comprehensively explore the key genes and specific modification sites of RNA acetylation modification, as well as the specific mechanism o by which RNA acetylation affects the response to immunotherapy in colorectal cancer.